Your browser doesn't support javascript.
loading
Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Birkner, Benjamin; Rech, Jürgen; Stargardt, Tom.
Affiliation
  • Birkner B; Hamburg Center for Health Economics (HCHE), Universität Hamburg, Hamburg, Germany.
  • Rech J; Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Department of Internal Medicine 3 - Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
  • Stargardt T; Hamburg Center for Health Economics (HCHE), Universität Hamburg, Hamburg, Germany.
PLoS One ; 15(1): e0226754, 2020.
Article in En | MEDLINE | ID: mdl-31895926
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Quality of Life / Biological Therapy / Cost-Benefit Analysis / Antirheumatic Agents / Withholding Treatment Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Quality of Life / Biological Therapy / Cost-Benefit Analysis / Antirheumatic Agents / Withholding Treatment Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: Alemania